Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs Standard Lithium Ltd — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.39B), while Standard Lithium Ltd trades at $2.45 (market cap $624.94M). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is far larger — about 15× Standard Lithium Ltd's market cap, and Bio-Rad Laboratories, Inc. Class A Common Stock is trading nearer its 52-week high, Standard Lithium Ltd nearer its low. Which is the better fit depends on your goals.
| BIO | SLI | |
|---|---|---|
Market Cap | $9.39B | $624.94M |
Sector | Health | Basic Materials |
52-Week High | $356.25 | $5.65 |
52-Week Low | $241.71 | $1.93 |
Enterprise Value | $9.14B | $484.14M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BIO trades at $352.47, up 2.93% today, near its consensus price target of $350. The stock shows a bullish technical trend with strong moving average signals, though RSI levels indicate overbought conditions. Fundamentally, Q2 2026 earnings beat expectations at $2.62 EPS, but revenue remains flat at $2.58 billion in 2025. The company has returned to profitability with a net income of $759.9 million after losses in prior years, supported by a solid gross margin of 51.9%.
The outlook is cautiously optimistic with analyst consensus at Buy (53.85%), but high P/E of 43.18 suggests premium valuation. Risks include revenue stagnation and sensitivity to academic research funding. Upside is supported by positive cash flow trends and institutional accumulation, yet investors should weigh valuation against growth prospects.
Standard Lithium (SLI) trades at $2.37, up 4.41% with a bullish technical signal despite mixed earnings performance. The company maintains 100% analyst buy ratings and strong institutional interest, including Amundi's 64.9% stake increase. Recent developments show progress toward final investment decision for the South West Arkansas lithium project, supported by a $225M DOE grant and key construction contracts. Financials reflect development-stage challenges with negative profitability metrics but substantial financing activity.
Outlook remains constructive as SLI transitions toward production with major project de-risking, though execution risks and negative cash flows warrant monitoring. The stock presents growth potential in lithium sector expansion but faces operational and funding challenges during development phase. Current valuation at 1.72x book value reflects market optimism about project economics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
